Please assess the completion status of the following clinical trial:

Trial Title: Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have clear intraocular media other than cataract.~* Subjects must have a clinically documented diagnosis of age-related bilateral cataracts that are considered amenable to treatment with standard phacoemulsification cataract extraction.~* Subjects must be undergoing primary IOL implantation for the correction of aphakia following central continuous curvilinear anterior capsulorrhexis and phacoemulsification cataract extraction.~* Subjects must require a spherical lens power from 10.00 D to 30.00 D.~* Subjects must be willing and able to return for all scheduled follow-up examinations for each eye from days 1 through 180 following surgery.~* Subjects must have ≤ 1.25 D of preoperative corneal astigmatism.~Exclusion Criteria:~* Subjects with corneal pathology potentially affecting topography.~* Subjects whose fundus cannot be assessed preoperatively.~* Subjects with diagnoses of degenerative visual disorders (eg, macular degeneration, or other retinal disorders) that cause potential acuity losses to a level worse than 20/30 as verified by OCT.~* Subjects with conditions with increased risk of zonular rupture, such as pseudoexfoliation syndrome.~* Subjects who have any active inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis.~* Subjects with uncontrolled glaucoma.~* Subjects with previous retinal detachment.~* Subjects with visually significant diabetic retinopathy (proliferative or non-proliferative) which reduces potential acuity to 20/30 or worse.~* Subjects with rubella, bilateral congenital, traumatic, complicated or polar cataract.~* Subjects with marked microphthalmos or aniridia.~* Subjects who have had previous corneal surgery.~* Subjects with irregular corneal astigmatism.~* Subjects with amblyopia which reduces potential acuity to worse than 20/30.~* Subjects with optic atrophy.~* Subjects with iris neovascularization.~* Subjects with clinically significant retinal pigment epithelium/macular changes which reduces potential acuity to 20/30 or worse.~* Subjects with chronic use of systemic steroids or immunosuppressive medications.~* Subjects lacking intact binocular vision.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Crystalens AO (Type: EXPERIMENTAL): A silicone multi-piece accommodating intraocular lens
- SoftPort LI61AO (Type: ACTIVE_COMPARATOR): A silicone multi-piece foldable aspheric intraocular lens

Based on this trial design, predict the completion outcome and termination type (if applicable).